Neogenomics Inc (NASDAQ:NEO)’s 12-Month Price Target Currently Stands At 18

In last trading session, Neogenomics Inc (NASDAQ:NEO) saw 1.15 million shares changing hands with its beta currently measuring 1.23. Company’s recent per share price level of $11.86 trading at -$0.86 or -6.76% at ring of the bell on the day assigns it a market valuation of $1.52B. That closing price of NEO’s stock is at a discount of -61.13% from its 52-week high price of $19.11 and is indicating a premium of 9.87% from its 52-week low price of $10.69.

For Neogenomics Inc (NEO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Neogenomics Inc (NASDAQ:NEO) trade information

Upright in the red during last session for losing -6.76%, in the last five days NEO remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $11.86 price level, adding 19.48% to its value on the day. Neogenomics Inc’s shares saw a change of -28.03% in year-to-date performance and have moved -13.93% in past 5-day. Neogenomics Inc (NASDAQ:NEO) showed a performance of -16.36% in past 30-days.

Wall Street analysts have assigned a consensus price target of 18 to the stock, which implies a rise of 34.11% to its current value. Analysts have been projecting 18 as a low price target for the stock while placing it at a high target of 18. It follows that stock’s current price would drop -51.77% in reaching the projected high whereas dropping to the targeted low would mean a loss of -51.77% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around 62.34% while estimates for its earnings growth in next 5 years are of 76.68%.

Neogenomics Inc (NASDAQ:NEO)’s Major holders

BLACKROCK INC. is the top institutional holder at NEO for having 19.67 million shares of worth $272.82 million. And as of 2024-06-30, it was holding 15.5612 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 14.12 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.1716 of outstanding shares, having a total worth of $195.87 million.